Page 118 - Oncology Coder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncology coder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncology Coder Today - Breaking & Trending Today

United States Non-Squamous Non-Small-Cell Lung Cancer

Dublin, May 26, 2023 (GLOBE NEWSWIRE) The "Non-Squamous Non-Small-Cell Lung Cancer in the United States, 2022-2042: Cancer Populations USA Report and. ....

Puerto Rico , United States , American Joint Committee On Cancer , Squamous Non Small Cell Lung Cancer , Cancer Populations United States Report , Populations United States , American Joint Committee , Cancer Populations United States , Topics Covered , Research And Markets , Lung Cancer , Solid Tumor ,

#VisualAbstract: Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. ....

Minute Medicine Inc , Colorectal Cancer , Trifluridine Tipiracil ,

Quizartinib improves overall median survival in patients with acute myeloid leukemia

1. Overall survival in the quizartinib group was 31.9 months compared to 15.1 months in the placebo group. 2. Proportion of adverse events in both groups was comparable between groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Acute myeloid leukemia (AML) is an aggressive form of blood cancer with poor clinical outcomes. In patients with ....

Rating Level , Previously Untreated Acute Myeloid , Between Sept , Acute Myeloid Leukemia , Blood Cancer , Hematologic Malignancy , Chronic Disease ,

High body mass index associated with increased risk of gastrointestinal cancers

1. Individuals with an overweight or obese body mass index (BMI) are at increased risk for developing colorectal cancer and non-colorectal gastrointestinal cancers. Evidence Rating Level: 2 (Good) Colorectal cancer (CRC) is the 5th most common cancer diagnosed in the United States. Though screening programs have improved the early detection and treatment of CRC, it ....

United States , Rating Level , Cancer Screening Trial , Colon Cancer , Colorectal Cancer , Chronic Disease ,

Locals participate in run/walk at Idlewild Park to raise funds for prostate cancer research

The Run/Walk promotes disease awareness, educates men about their risk, and raises critical funding to support patients and families. ....

Idlewild Park , United States , Tracy Cesaretti , Jamie Bearse , American Cancer Society , Urology Nevada , He Economy ,